WMA Declaration of Helsinki – Ethical Principles f... ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
A Professional Overview of Hypertension ...
Long-term physical activity protects against metabolic syndr...
January 17,2026
Controlling hypertension can reduce dementia risk—even when ...
January 16,2026
Assessing methods for improving access to trauma care for ki...
January 15,2026
Portable device could help scientists track Alzheimer's dise...
January 14,2026
Neurons use physical signals, not electricity, to stabilize ...
January 13,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Dr. Fauci among hundreds who've contract...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
Announcement of the 2025 Nobel Prize in ...
More News
Scientists develop first bone marrow model that supports human stem cells

Scientists develop first bone marrow model that supports human stem cells

byUniversity of GlasgowSchematic of the bone marrow (BM) niche microenvironment. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50054-0Scientists have created the first
Oncology August 03,2024
Scientists develop first bone marrow model that supports human stem cells

Scientists develop first bone marrow model that supports human stem cells

byUniversity of GlasgowSchematic of the bone marrow (BM) niche microenvironment. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50054-0Scientists have created the first
Oncology August 03,2024
Researchers discuss HER2-low and HER2-zero in breast cancer

Researchers discuss HER2-low and HER2-zero in breast cancer

by Impact Journals LLCMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaA new editorial paper titled &quot
Oncology August 03,2024
Researchers discuss HER2-low and HER2-zero in breast cancer

Researchers discuss HER2-low and HER2-zero in breast cancer

by Impact Journals LLCMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaA new editorial paper titled &quot
Oncology August 03,2024
Eliminating senescent cells could help treat breast, pancreatic cancers

Eliminating senescent cells could help treat breast, pancreatic cancers

byWashington University in St. LouisShown is a human breast tumor sample. The white arrows point to senescent cells in the tumor. Eliminating senescent cells, which drive inflammation, could bec
Oncology August 03,2024
Eliminating senescent cells could help treat breast, pancreatic cancers

Eliminating senescent cells could help treat breast, pancreatic cancers

byWashington University in St. LouisShown is a human breast tumor sample. The white arrows point to senescent cells in the tumor. Eliminating senescent cells, which drive inflammation, could bec
Oncology August 03,2024
Knockout of CD5 on CAR T cells shown to boost anti-tumor efficacy

Knockout of CD5 on CAR T cells shown to boost anti-tumor efficacy

byPerelman School of Medicine at the University of PennsylvaniaCD5 KO enhances CAR T cell cytotoxicity. Credit:Science Immunology(2024). DOI: 10.1126/sciimmunol.adn6509The effectiven
Oncology August 03,2024
Knockout of CD5 on CAR T cells shown to boost anti-tumor efficacy

Knockout of CD5 on CAR T cells shown to boost anti-tumor efficacy

byPerelman School of Medicine at the University of PennsylvaniaCD5 KO enhances CAR T cell cytotoxicity. Credit:Science Immunology(2024). DOI: 10.1126/sciimmunol.adn6509The effectiven
Oncology August 03,2024
Testosterone therapy may protect against breast cancer in trans masculine individuals

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c
Oncology August 03,2024
Testosterone therapy may protect against breast cancer in trans masculine individuals

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c
Oncology August 03,2024
Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,
Oncology August 03,2024
Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,
Oncology August 03,2024
Long-term results from testicular cancer treatment are positive, study shows

Long-term results from testicular cancer treatment are positive, study shows

byUniversity College CorkCredit: Pixabay/CC0 Public DomainA new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even aft
Oncology August 03,2024
Long-term results from testicular cancer treatment are positive, study shows

Long-term results from testicular cancer treatment are positive, study shows

byUniversity College CorkCredit: Pixabay/CC0 Public DomainA new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even aft
Oncology August 03,2024
Computational tool integrates transcriptomic data to enhance breast cancer diagnosis and treatment

Computational tool integrates transcriptomic data to enhance breast cancer diagnosis and treatment

by Nik Papageorgiou,Ecole Polytechnique Federale de LausanneClinical validation of EMBER. Credit:npj Breast Cancer(2024). DOI: 10.1038/s41523-024-00665-zAddressing problems with diag
Oncology August 03,2024
Computational tool integrates transcriptomic data to enhance breast cancer diagnosis and treatment

Computational tool integrates transcriptomic data to enhance breast cancer diagnosis and treatment

by Nik Papageorgiou,Ecole Polytechnique Federale de LausanneClinical validation of EMBER. Credit:npj Breast Cancer(2024). DOI: 10.1038/s41523-024-00665-zAddressing problems with diag
Oncology August 03,2024
Ophthalmologic manifestations of acute leukemia are heterogeneous

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp
Oncology August 03,2024
Ophthalmologic manifestations of acute leukemia are heterogeneous

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp
Oncology August 03,2024
AI model identifies certain breast tumor stages likely to progress to invasive cancer

AI model identifies certain breast tumor stages likely to progress to invasive cancer

by Adam ZeweA large-scale high-resolution chromatin imaging dataset enables the analysis of disease stages and phenotypic categories in DCIS. Credit:Nature Communications(2024). DOI: 10.10
Oncology August 03,2024
AI model identifies certain breast tumor stages likely to progress to invasive cancer

AI model identifies certain breast tumor stages likely to progress to invasive cancer

by Adam ZeweA large-scale high-resolution chromatin imaging dataset enables the analysis of disease stages and phenotypic categories in DCIS. Credit:Nature Communications(2024). DOI: 10.10
Oncology August 03,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... Health spending has been rising across rich countries with different systems ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com